Feasibility of developing live attenuated HIV vaccines: conclusions and recommendations. World Health Organization Working Group.
D016915:AIDS Vaccines; D000818:Animals; D005240:Feasibility Studies; D015658:HIV Infections / Q000517:prevention & control*; D006801:Humans; D016097:Simian Acquired Immunodeficiency Syndrome / Q000517:prevention & control; D014613:Vaccines, Attenuated; D014944:World Health Organization
D016915:AIDS Vaccines; D014613:Vaccines, Attenuated